This company has been marked as potentially delisted and may not be actively trading. Novan (NOVN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Novartis AGFebruary 27, 2024 | wsj.comNovartis AG Registered SharesFebruary 16, 2024 | morningstar.comNovartis AG Registered Shares NOVNOctober 31, 2023 | morningstar.comNovan reaches deals to sell assets in bankruptcy caseSeptember 8, 2023 | bizjournals.comFirm Retention Summary: NovanAugust 8, 2023 | msn.comNovan (NOVN) Price Target Increased by 43.52% to 15.81August 3, 2023 | msn.comNovan Shares Hit 52-Week Low After Bankruptcy DeclarationJuly 17, 2023 | marketwatch.comTrading was temporarily halted for "NOVN" at 08:07 AM with a stated reason of "News pending."July 17, 2023 | marketbeat.comNovan cuts 50% of its workforce to extend runwayJune 1, 2023 | bizjournals.comNovan drops 13%, will reduce workforce by 50%June 1, 2023 | msn.comNovan To "Sharpen" Focus, Resources On Berdazimer GelMay 31, 2023 | markets.businessinsider.comNovan Focuses Strategic Direction and Announces RestructuringMay 31, 2023 | finance.yahoo.comTrading was temporarily halted for "NOVN" at 04:05 PM with a stated reason of "News pending."May 31, 2023 | marketbeat.comNovan (NASDAQ: NOVN)May 21, 2023 | fool.comOppenheimer Maintains Novan (NOVN) Outperform RecommendationMay 17, 2023 | msn.comNOVN: Counting Down to PDUFAMay 16, 2023 | finance.yahoo.comNovan, Inc.: Novan Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 15, 2023 | finanznachrichten.deNovan earnings: here's what Wall Street expectsMay 15, 2023 | markets.businessinsider.comEarnings Preview: NovanMay 12, 2023 | msn.comNovan Q1 2023 Earnings PreviewMay 12, 2023 | msn.comNovan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhDApril 20, 2023 | finance.yahoo.comNovan's Return On Capital Employed OverviewApril 3, 2023 | msn.comNovan to Report Full Year 2022 Financial Results on March 30, 2023March 23, 2023 | finance.yahoo.comFDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024March 7, 2023 | finance.yahoo.comJPMorgan names Qian as Southeast Asia equity capital markets chief - ReutersOctober 19, 2022 | reuters.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® - Yahoo FinanceOctober 14, 2022 | finance.yahoo.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference - GlobeNewswireOctober 14, 2022 | globenewswire.comNovan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®October 14, 2022 | finance.yahoo.comGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - Yahoo FinanceOctober 6, 2022 | finance.yahoo.comWorldwide Acne Treatment Industry to 2027 - Focus on Retinoids, Antibiotics, Hormonal Drugs, Anti-Inflammatory Drugs and Chemical Peels - Yahoo FinanceOctober 3, 2022 | finance.yahoo.comOutlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth - GlobeNewswireSeptember 22, 2022 | globenewswire.comEPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference - StreetInsider.comSeptember 15, 2022 | streetinsider.comNovan (NASDAQ:NOVN) – Novan Announces That EPI Health, A Novan Company, And MC2 Therapeutics Presented Da - BenzingaSeptember 15, 2022 | benzinga.comEPI Health, a Novan Company, and MC2 Therapeutics Present - GlobeNewswireSeptember 15, 2022 | globenewswire.comNOVN.OQ - Novan Inc | Stock Price & Latest News | ReutersSeptember 5, 2022 | reuters.comGenital Warts Market Size to Register Subsequent Growth by 2032 as Key Players Such as Verrica Pharmaceuticals, Tamir Biotechnology, Novan Inc., and others are Looking for Opportunities | DelveInsight - Yahoo FinanceAugust 30, 2022 | finance.yahoo.comNOVN.A - Novan Inc | Stock Price & Latest News | ReutersAugust 28, 2022 | reuters.comNOVN: EPI Revenue Trends Are Strong - BenzingaAugust 17, 2022 | benzinga.comNovan: Q2 Earnings Snapshot - Greenwich TimeAugust 13, 2022 | greenwichtime.comNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Yahoo FinanceAugust 12, 2022 | finance.yahoo.comPreparing and Aligning Your Biotech Organization for Commercial Success, Upcoming Webinar Hosted by Xtalk - BenzingaAugust 11, 2022 | benzinga.comNovan Reports Second Quarter 2022 Financial Results and Provides Corporate Update - GlobeNewswireAugust 11, 2022 | globenewswire.comNovan Q2 2022 Earnings Preview (NASDAQ:NOVN) - Seeking AlphaAugust 10, 2022 | seekingalpha.comNovan phase 3 trial results published in JAMA amid FDA push - Triangle Business Journal - The Business JournalsJuly 21, 2022 | bizjournals.comGlobal Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027 - Yahoo FinanceJuly 19, 2022 | finance.yahoo.comNovan stock gains; Oppenheimer begins coverage at Outperform on SB206's market potential - Seeking AlphaJuly 19, 2022 | seekingalpha.comNovan Satisfies $16.5 Million Outstanding Promissory Note - GlobeNewswireJuly 19, 2022 | globenewswire.comNovan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology - Yahoo FinanceJuly 13, 2022 | finance.yahoo.comNovan Announces Publication Of Results From Pivotal Phase 3 Study Of Berdazimer Gel, 10.3% (SB206) In Patients With Molluscum Contagiosum In JAMA Dermatology - BenzingaJuly 13, 2022 | benzinga.comNovan Announces Publication of Positive Results from Pivotal Phase 3 Study of Berdazimer Gel, 10.3% (SB206) in Patients with Molluscum Contagiosum in JAMA Dermatology - PR NewswireJuly 13, 2022 | prnewswire.com Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address NOVN Media Mentions By Week NOVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NOVN News Sentiment▼0.000.86▲Average Medical News Sentiment NOVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NOVN Articles This Week▼00▲NOVN Articles Average Week Get Novan News Delivered to You Automatically Sign up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Incannex Healthcare News Today GeoVax Labs News Today Scienture News Today NextCure News Today Dogwood Therapeutics News Today Hoth Therapeutics News Today Flora Growth News Today BioLineRx News Today Sensei Biotherapeutics News Today Portage Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NOVN) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novan With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
